Department of Pharmaceutics, School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, Liaoning, China.
Affiliated Hospital of Inner Mongolia University for the Nationalities, Tongliao 028000, Neimenggu, China.
J Control Release. 2021 May 10;333:269-282. doi: 10.1016/j.jconrel.2021.03.041. Epub 2021 Mar 30.
Periodontitis is a chronic inflammation of the soft tissue surrounding and supporting the teeth, which causes periodontal structural damage, alveolar bone resorption, and even tooth loss. Its prevalence is very high, with nearly 60% of the global population affected. Hence, periodontitis is an important public health concern, and the development of effective healing treatments for oral diseases is a major target of the health sciences. Currently, the application of local drug delivery systems (LDDS) as an adjunctive therapy to scaling and root planning (SRP) in periodontitis is a promising strategy, giving higher efficacy and fewer side effects by controlling drug release. The cornerstone of successful periodontitis therapy is to select an appropriate bioactive agent and route of administration. In this context, this review highlights applications of LDDS with different properties in the treatment of periodontitis with or without systemic diseases, in order to reveal existing challenges and future research directions.
牙周炎是一种慢性炎症,会影响牙齿周围和支撑牙齿的软组织,导致牙周结构破坏、牙槽骨吸收,甚至牙齿脱落。它的发病率非常高,全球近 60%的人口受到影响。因此,牙周炎是一个重要的公共卫生关注点,开发针对口腔疾病的有效治疗方法是健康科学的主要目标之一。目前,局部药物输送系统 (LDDS) 作为牙周炎的辅助治疗方法,与龈下刮治和根面平整 (SRP) 联合应用是一种很有前途的策略,通过控制药物释放,可以提高疗效,减少副作用。成功治疗牙周炎的关键是选择合适的生物活性药物和给药途径。在这种情况下,本综述强调了具有不同特性的 LDDS 在治疗伴有或不伴有系统性疾病的牙周炎中的应用,以揭示现有挑战和未来的研究方向。